Park West Asset Management’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
PIM
HA
JHIU
LAM
FWSM
SCM
2L
SM
Park West Asset Management's TRIB Position: Q4 2016 in Review
Park West Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 170,669 shares — an estimated $11.3M sold.
Park West Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $13.9M in Q2 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.
- Park West Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
- Park West Asset Management sold 170,669 Trinity Biotech shares in Q4 2016, an estimated $11.3M.
- Park West Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
- Park West Asset Management's Trinity Biotech position peaked at $13.9M in Q2 2015.
- 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.
Based on Park West Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.